| Name | di-tert-butyl (2S,2'S)-2,2'-(4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate) |
|---|---|
| Synonyms |
Daclatasvir Intermediates Ⅱ
Di-tert-butyl2,2'-([1,1'-biphenyl]-4,4'-diylbis(1H-imidazole-5,2-diyl))(2S,2'S)-bis(pyridineidine-1 1,1'-Bis(tert-butyl) (2S,2'S)-2,2'-(biphenyl-4,4'-diyldi-1H-imidazol-5,2-diyl)bis[pyrrolidine-1-cboxylate Bis(2-methyl-2-propanyl) (2S,2'S)-2,2'-[4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecboxylate) 2-(5-(4'-(2-((S)-1-(tert-butoxycbonyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidine-1-cboxylate Daclatasvir Intermediate-2 T5NTJ AVOX1&1&1 B- BT5M CNJ ER DR D- ET5M CNJ B- BT5NTJ AVOX1&1&1 &&(2S,2S'- Form di-tert-butyl (2S,2'S)-2,2'-(4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-pyrrolidinecboxylate) Bis(2-methyl-2-propanyl) (2S,2'S)-2,2'-[4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecarboxylate) 2-(4-{4'-[2-((2S)-1-tert-butoxycbonyl-pyrrolidin-2-yl)-1H-imidazol-4-yl]-biphenyl-4-yl}-1H-imidazol-2-yl)-(2S)-pyrrolidine-1-cboxylic acid tert-butyl ester 1-Pyrrolidinecboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diy Di-tert-butyl2,2'-([1,1'-biphenyl]-4,4'-diylbis(1H-imidazole-5,2-diyl))(2S,2'S)-bis(pyridineidine-1-cboxylate) 1-Pyrrolidinecboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S) di-tert-butyl (2S,2'S)-2,2'-(4,4'-biphenyldiylbis(lH-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate) Intermediate II of Dacatavir 1-Pyrrolidinecboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)-nyl (2S,2''S)-Di-tert-butyl 2,2''-(5,5''-([1,1''-biphenyl]-4,4''-diyl)bis(1h-imidazole-5,2-diyl))bis(pyrrolidine-1-cboxylate) (2S,2'S) Daclatasvir Intermediates Bis(1,1-dimethylethyl) (2,2'-[[1,1'-biphenyl]-4,4'-diylbis(1H-imidazole-5,2-diyl)]bis(1-pyrrolidinecarboxylate) 1-Pyrrolidinecboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H Daclatasvir intermediate 02 HCV-IN-30, 10 mM in DMSO Daclatasvir Intermediates 4 (2S,2'S)-2,2'-[(1,1'-biphenyl)-4,4'-diyldi-1H-imidazole-5,2-diyl]bis-1-pyrrolidinecboxylic acid ,1,1'-bis(1,1-dimethylethyl) ester Dacaltasvir Intermediate 02 (2S,2'S)-DI-TERT-BUTYL-2,2'-(4,4'-([1,1'-BIPHENYL]-4,4'-DIYL - )BIS(1H-IMIDAZOLE-4,2-DIYL))BIS(PYRROLIDINE-1-CARBOXYLATE) Daclatasvir intermediate 1-Pyrrolidinecboxylic acid,2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-imidazole-5,2-diyl)bis 1,1'-Bis(1,1-dimethylethyl) (2S,2'S)-2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-imidazole-5,2-diyl)bis[1-pyrrolidinecboxylate Methyl-N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]cbamate Di-tert-butyl (2S,2'S)-2,2'-(4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate) di-tert-butyl(2S,2'S)-2,2'-(4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-pyrrolidinecarboxylate) di-tert-butyl2,2'-([1,1'-biphenyl]-4,4'-diylbis(1H-imidazole-5,2-diyl))(2S,2'S)-bis(pyrrolidine-1-cboxylate) (2S,2'S)-2,2'-([1,1'-Biphenyl]-4,4'-diyldi-1H-imidazole-5,2-diyl)bis-1-pyrrolidinecboxylic acid 1,1'-bis(1,1-dimethylethyl) ester (2S,2'S)-di-tert-butyl 2,2'-(4,4'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-iMidazole-4,2-diyl))bis(pyrrolidine-1-cboxylate) EOS-61352 |
| Description | HCV-IN-30 (compound 48) is a HCV NS5A replication complex inhibitor, with IC50s of 901 and 102 nM for genotypes 1a and 1b replicons, respectively[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 890.2±65.0 °C at 760 mmHg |
| Molecular Formula | C36H44N6O4 |
| Molecular Weight | 624.772 |
| Flash Point | 492.2±34.3 °C |
| Exact Mass | 624.342407 |
| PSA | 116.44000 |
| LogP | 5.69 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.600 |